A Phase I Study of GC33 plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
[Protocol 10-021] |
Abou-Alfa, Ghassan, MD |
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117] |
Schwartz, Gary, MD |
A Phase II Study of CO-1.01 for Gemcitabine-Refractory Patients with Stage IV Pancreatic Cancer
[Protocol 10-210] |
O'Reilly, Eileen, MD |
A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma
[Protocol 07-113] |
O'Reilly, Eileen, MD |
A Phase III Study of ADI-PEG20/Supportive Care or Placebo/Supportive Care in Patients with Advanced Liver Cancer
[Protocol 11-081] |
Abou-Alfa, Ghassan, MD |
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer
[Protocol 10-083] |
Goodman, Karyn, MD |
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
[Protocol 11-194] |
Ginex, Pamela, RN, EDD |
A Study Comparing Beads with Doxorubicin-Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
[Protocol 07-099] |
Brown, Karen, MD |
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
[Protocol 02-102] |
Kurtz, Robert, MD |
Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer
[Protocol 11-039] |
Abou-Alfa, Ghassan, MD |
Treatment of Children with All Stages of Hepatoblastoma
[Protocol 10-046] |
Kobos, Rachel, MD |
